Compounds > nifedipine

nifedipine and sirolimus

nifedipine has been researched along with sirolimus in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M1
Andricopulo, AD; Moda, TL; Montanari, CA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1
Elia, MG; Greco, S; Jiménez, E; Marsigliante, S; Muscella, A; Storelli, C1
Kwon, G; Liu, H; Marshall, CA; McDaniel, ML; Pappan, KL; Remedi, MS1
Goto, T; Hiramoto, T; Horiguchi, S; Inoue, K; Ishida, E; Kato, A; Miyata, S; Nakamura, A; Nozaki, E; Shimokawa, H; Shinozaki, T; Sugi, M; Takahashi, J; Tsuburaya, R; Yamamoto, Y; Yasuda, S1

Reviews

2 review(s) available for nifedipine and sirolimus

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022

Trials

1 trial(s) available for nifedipine and sirolimus

ArticleYear
Beneficial effects of long-acting nifedipine on coronary vasomotion abnormalities after drug-eluting stent implantation: The NOVEL study.
    European heart journal, 2016, Sep-14, Volume: 37, Issue:35

    Topics: Coronary Disease; Drug-Eluting Stents; Everolimus; Humans; Nifedipine; Prospective Studies; Sirolimus; Treatment Outcome

2016

Other Studies

6 other study(ies) available for nifedipine and sirolimus

ArticleYear
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
    Biochemical and biophysical research communications, 2004, Mar-19, Volume: 315, Issue:4

    Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity

2004
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Muscarinic acetylcholine receptor activation induces Ca2+ mobilization and Na+/K+-ATPase activity inhibition in eel enterocytes.
    The Journal of endocrinology, 2002, Volume: 173, Issue:2

    Topics: Analysis of Variance; Animals; Calcineurin Inhibitors; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Carbachol; Cholinergic Agonists; Dose-Response Relationship, Drug; Eels; Enterocytes; Enzyme Activation; Enzyme Inhibitors; Naphthalenes; Nifedipine; Protein Kinase C; Receptors, Cholinergic; Sirolimus; Sodium; Sodium-Potassium-Exchanging ATPase; Tacrolimus; Thapsigargin; Type C Phospholipases

2002
Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels: effects on cell cycle progression in rodent islets.
    The Journal of biological chemistry, 2006, Feb-10, Volume: 281, Issue:6

    Topics: Animals; Blotting, Western; Calcium; Cell Cycle; Cell Division; Cell Proliferation; Cells, Cultured; Cytosol; Diazoxide; Dose-Response Relationship, Drug; Flow Cytometry; G2 Phase; Glucose; Glyburide; Islets of Langerhans; Male; Nifedipine; Potassium; Potassium Channels; Protein Kinases; Rats; Rats, Sprague-Dawley; S Phase; Sirolimus; Thymidine; TOR Serine-Threonine Kinases

2006